DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20182292

A study of Acinetobacter infections in a tertiary care hospital in Northeast India

Swarnatrisha Saha, Ksh Mamta Devi, Shan Damrolien, Kh Sulochana Devi

Abstract


Background: Acinetobacter is an important opportunistic pathogen and is a common cause of hospital acquired infections. Acinetobacter infections are often extremely difficult to treat because of their widespread resistance to the major groups of antibiotics. The study was conducted to determine prevalence and antibiotic susceptibility pattern of Acinetobacter species isolated from various clinical samples.

Methods: Clinical specimens over a period of 2yrs from May 2015 to April 2017 were collected from the patients attending the hospital. Acinetobacter species isolates were identified, and antibiotic susceptibility test was done following standard operative procedures.

Results: From 9979 clinical specimens, 3715 were positive for significant bacterial growth of which 111 (2.9%) were culture positive for Acinetobacter spp. Among 111 isolates 109 (98.2%) isolates were Acinetobacter baumanni and 2 (1.8%) were Acinetobacter lwoffii. Maximum isolates were isolated from urine samples 36 (32.4%) and majority of the isolates were from wards (56.7%) giving a probability of increased hospital acquired infections. Maximum resistance was shown by cefipime (80.1%). Imipenem and Meropenem shows resistance of 25.3% and 29.7% respectively. ICU isolates showed extensive resistance in comparison to wards and OPD.

Conclusions: Increasing trend of resistance pattern to a large range of antibiotics is a matter of concern. To avoid resistance, antibiotics should be used judiciously, and empirical therapy should be determined for each hospital according to the resistance rates of the hospital. Infection with MDR Acinetobacter species is independently associated with high mortality, emphasizing the need for aggressive infection control strategies.


Keywords


Antibiotic susceptibility, Empirical therapy, Hospital acquired infections, Infection control strategies

Full Text:

PDF

References


Gautam V, Singhal L, Ray P. Burkholoderia cepacia complex: Beyond Pseudomonas and Acinetobacter. Ind J Med Microbiol. 2011;29:4-12.

Winn W, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, et al. Non-fermenting Gram negative bacilli In: Koneman'scolor Atlas and textbook of Diagnostic Microbiology. 6th ed. USA: Lippincott Williams and Wilkins Company; 2006:305-91.

Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148-65.

Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. J Crit Care Med. 2001:29:64-8.

Dash M, Padhi S, Patnaik S, Mohanty I, Misra P. Frequency, risk factors and antibiogram of Acinetobacter species isolated from various clinical samples in a tertiary care hospital in Odisha, India. Avicenna J Med. 2013;3(4):97-102.

Rekha S, Gokul BN, Beena PM, Prasad SR. Multidrug resistant Acinetobacter isolates from patients admitted at Kolar. J Clin Biomed Sci. 2011;1:3-7.

Lyytikainen O, Koljalg S, Harma M, Vuopio-Varkila J. Outbreakcaused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem. J Hosp Infect. 1995;31:41-54.

Tille PM. Bailey and Scott’s Diagnostic Microbiology, 13th edition. St. Louis, Missouri: Elsevier; 2014:193-231.

Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45:493-6.

Clinical Laboratory Standards Institutes (CLSI). Performance standards for antimicrobial susceptibility testing. 26th ed. CLSI supplement M100S. Wayne, PA: Clinical and Laboratory Standards Institute. 2016 Jan;36(1):40-256

Bradford PA. Extended spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-51.

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug resistant, extensively drug resistant and pandrug resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-81.

Adams-Haduch JM, Paterson DL, Sidjabat HE, Pasculle AW, Potoski BA, Muto CA, et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother. 2008;52:3837-43.

Gupta N, Gandham N, Jadhav S, Mishra RN. Isolation and identification of Acinetobacter species with special reference to antibiotic resistance. J Nat Sc Biol Med. 2015;6:159-62.

Mostofi S, Mirnejad R, Masjedian F. Multi-drug resistance in Acinetobacter baumannii strains isolated from clinical specimens from three hospitals in Tehran-Iran. Afr J Microbiol Res. 2011;5:3579-82.

Joshi SG, Litake GM, Satpute MG, Telang NV, Ghole VS, Niphadkar KB. Clinical and demographic features of infection caused by Acinetobacter species. Ind J Med Sci. 2006;60:351-60.

Guckan R, Kilinc C, Demir AD, Capraz A, Yanik K. Antimicrobial susceptibility of acinetobacter baumannii complex isolated from different clinical samples in a tertiary care hospital. J Antibiotics Research. 2015;01(01).

Bhattacharyya S, Bhattacharyya I, Rit K, Mukhopadhyay PK, Dey JB, Ganguly U, et al. Antibiogram of Acinetobacter spp. isolated from various clinical specimens in a tertiary care hospital, West Bengal, India. Biomed Res. 2013;24:43-6.

Shareek PS, Sureshkumar D, Ramagopalakrishnan S, Ramasubramanian V, Abdul Ghafur K, Thirunarayanan MA. Antibiotic sensitivity pattern of blood isolates of Acinetobacter species in a tertiary care hospital: A retrospective analysis. Am J Infect Dis. 2012;8:65-9.

Nahar A, Anwar S, Saleh AA, Miah RA. Isolation of Acinetobacter species and their antimicrobial resistance pattern in an Intensive Care Unit (ICU) of a tertiary care hospital in Dhaka, Bangladesh. Bangladesh J Med Microbiol. 2012;06(01):3-6.